Determining the Effect of Delivery Rate on Glucose Uptake by Cancer Cells by Felton, Luke
University of Arkansas, Fayetteville
ScholarWorks@UARK
Biomedical Engineering Undergraduate Honors
Theses Biomedical Engineering
5-2016
Determining the Effect of Delivery Rate on
Glucose Uptake by Cancer Cells
Luke Felton
University of Arkansas, Fayetteville
Follow this and additional works at: http://scholarworks.uark.edu/bmeguht
Part of the Bioimaging and Biomedical Optics Commons
This Thesis is brought to you for free and open access by the Biomedical Engineering at ScholarWorks@UARK. It has been accepted for inclusion in
Biomedical Engineering Undergraduate Honors Theses by an authorized administrator of ScholarWorks@UARK. For more information, please
contact scholar@uark.edu.
Recommended Citation
Felton, Luke, "Determining the Effect of Delivery Rate on Glucose Uptake by Cancer Cells" (2016). Biomedical Engineering
Undergraduate Honors Theses. 36.
http://scholarworks.uark.edu/bmeguht/36
1	
Abstract	
Radiation	therapy	is	one	of	the	most	commonly	performed	cancer	treatment	therapies	today.	Radiation	therapy	can	cause	can	changes	to	tumor	vasculature	and	affect	blood	flow	rates.	It	is	important	to	determine	how	changes	in	blood	flow	rates	affect	tumor	glycolytic	uptake	to	better	understand	tumor	response	to	radiation	therapy	(1).	The	goal	of	this	study	was	to	use	a	fluorescent	analog	of	glucose,	2-NBDG,	to	study	the	effect	of	varying	flow	rates	on	glucose	uptake.	A	microfluidic	device	was	constructed	to	flow	2-NBDG	through.	A	murine	metastatic	breast	cancer	cell	line	was	then	cultured	inside	this	microfluidic	channel,	and	2-NBDG	was	flowed	through	the	device	at	.5	microliters/min	for	20	minutes.	After	20	minutes,	the	device	was	imaged	using	fluorescence	microscopy.	The	2-NBDG	uptake	was	measured	for	only	one	flow	rate.	This	is	not	sufficient	evidence	to	determine	the	effect	of	varying	flow	rates	on	glucose	uptake.	Future	studies	should	be	conducted	at	increasing	flow	rates	to	determine	this	effect.		
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Introduction	
	One	characteristic	of	cancer	cells	is	heightened	glucose	uptake	in	comparison	to	normal	cells.	Quantifying	the	glucose	uptake	has	been	helpful	in	identifying	cancers,	and	determining	the	effect	of	radiation	therapy.	Positron	emission	tomography	has	been	a	widely	used	imaging	technique	to	quantify	glucose	uptake	in	the	clinic.	Though	widely	used,	this	method	provides	limited	information	concerning	the	metabolism	of	a	tumor.	This	technique	only	provides	the	glucose	uptake	at	a	single	point	in	time.	The	glucose	uptake	at	that	point	in	time	cannot	be	indicative	of	tumor	metabolic	activity	because	glucose	uptake	can	be	affected	by	multiple	factors.	Glucose	uptake	can	be	perfusion	dependent,	influenced	by	varying	flow	rates,	and	dependent	on	the	actual	metabolic	need	for	the	tumor.	Because	the	post-radiation	tumor	microenvironment	can	cause	severe	changes	to	the	tumor	microvasculature	and	hence	affect	the	delivery	of	contrast	agents,	it	is	important	to	understand	the	effect	of	blood	flow	rates	on	the	uptake	of	glucose	analogs.	The	initial	glucose	uptake	of	the	tumor	provides	insight	into	the	metabolic	demand	of	the	tumor,	helping	to	quantify	tumor	metastatic	potential	and	tumor	response	to	radiation	therapy.	It	is	important	to	determine	the	effect	of	varying	flow	rates	to	determine	the	actual	metabolic	demand	of	the	tumor	(1).		
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		It	has	been	shown	in	the	figure	above	that	2-NBDG	uptake	is	correlated	with	blood	velocity.	In	this	in	vivo	study,	mice	were	injected	with	breast	cancer	cells	to	form	a	tumor.	These	mice	were	then	subject	to	hypoxic	conditions,	and	the	blood	velocity	of	the	tumor	and	the	glucose	uptake	(Rd)	were	measured	before	and	after	hypoxia.	The	study	showed	that	as	the	blood	velocity	increased,	the	delivery	rate	of	glucose	increased,	suggesting	that	2-NBDG	uptake	is	dependent	on	flow	rate.	This	study	has	been	the	motivation	for	our	study	(2).	The	goal	of	our	study	was	to	isolate	the	effect	varying	flow	rates	on	glucose	uptake	so	that	more	information	on	initial	metabolic	demand	of	tumors	could	be	determined.	We	used	a	fluorescent	glucose	analog,	2-NBDG,	to	measure	glucose	uptake	in	murine	breast	cancer	cells.	This	analog	was	chosen	because	it	has	shown	to	be	a	suitable	molecule	for	measuring	glucose	uptake	in	previous	studies.	This	study	was	sectioned	into	three	main	aims:	to	create	a	suitable	device	for	2-NBDG	to	flow,	to	model	in	vivo	parameters	by	seeding	cells	inside	the	device	and	flowing	2-NBDG	at	flow	rates	similar	to	that	of	tumor	vasculature,	and	to	quantify	2-NBDG	uptake	through	fluorescence	imaging.	The	study	of	how	this	tracer	is	affected	with	varying	flow	rates	will	provide	valuable	
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information	concerning	the	identification	of	radiation	resistance	and	radiotherapy	response,	and	will	serve	as	a	valuable	model	for	future	in	vivo	studies.			
Methods		
Microfluidic	channel	fabrication		 The	microfluidic	channels	were	fabricated	using	a	silicone	wafer	constructed	at	the	High	Density	Electronic	Center,	located	at	the	University	of	Arkansas.	This	wafer	was	made	using	soft	lithography	techniques	with	a	channel	mold	and	photoresist	grafting	technique.	This	silicone	wafer	was	designed	to	construct	a	channel	with	a	width	of	500	microns	and	a	depth	of	50	microns.		(3).	65	grams	of	the	PDMS	elastomer	base	was	mixed	with	6.5	grams	of	the	elastomer	curing	agent	(10:1	ratio).	The	mixture	was	mixed	vigorously	for	10	minutes.	After	10	minutes,	the	mixture	was	degassed	and	poured	over	the	silicone	wafer.	The	PDMS	poured	over	the	wafer	was	then	placed	in	a	70°C	oven	for	3	hours	to	cure	the	PDMS.	Once	cured,	the	PDMS	was	peeled	from	the	silicone	wafer	and	cut	into	two	rectangular	shapes	using	a	glass	coverslip	as	a	guide.	The	portholes	were	then	made	with	a	biopsy	punch.	The	PDMS	molds	were	then	sonicated	for	30	minutes	in	100	ml	of	50%	pure	ethanol	and	50%	deionized	water	and	then	dried	with	air.	The	molds	and	two	glass	coverslips	were	then	placed	inside	an	UV/Ozone	machine	for	15	minutes.	After	15	minutes,	the	glass	coverslips	and	PDMS	were	attached	by	gently	pressing	each	PDMS	mold	onto	the	coverslip.	To	better	seal	the	attachment	of	the	glass	coverslip	and	mold,	PDMS	was	used	to	surround	the	coverslip.	15	grams	of	the	PDMS	
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elastomer	base	was	mixed	with	1.5	grams	of	the	elastomer	curing	agent.	This	solution	was	mixed	for	10	minutes	and	degassed.	This	mixture	was	used	to	surround	the	entire	parameter	of	the	coverslip	with	a	1	ml	syringe.	After	coated	with	the	PDMS	mixture,	the	device	was	placed	in	a	70°C	oven	for	3	hours	to	cure	the	surrounding	PDMS.	Once	cured,	the	excess	PDMS	was	removed	so	that	the	channel	could	be	easily	seen	inside	the	coverslip.			
	
Figure	1.	Microfluidic	channel.	The	channel	is	formed	by	attaching	a	PDMS	mold	to	a	glass	coverslip.	The	cells	are	then	cultured	on	the	coverslip.	
	
Cell	culturing		 4T1	cells,	a	metastatic	murine	breast	cancer	cell	line,	were	used	for	these	experiments.	4T1	cells	were	cultured	in	DMEM	with	the	addition	of	10%	fetal	bovine	serum	and	1%	antibiotics.	Prior	to	channel	injection,	20mM	of	Hepes	was	added	to	the	cell	suspension.	Gelatin	was	injected	inside	the	channel	prior	to	injecting	cells.	The	gelatin	remained	in	the	channel	for	1	hour	before	injecting	cells.	The	cells	were	injected	inside	the	channel	using	a	small	piece	of	tygon	tubing	and	a	syringe.	The	cells	were	then	incubated	at	37°C	for	90	minutes.	After	90	minutes,	the	
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cells	were	perfused	with	DMEM	at	1	microliter/hour	for	24-48	hours	inside	the	incubator.	After	the	incubation	period,	the	cells	were	imaged	with	2-NBDG.	
 	
Imaging	with	2-NBDG	
	 2-NBDG	fluorescence	was	measured	using	traditional	fluorescence	microscopy.	The	image	platform	consisted	of	an	inverted	fluorescence	microscope,	the	Olympus	IX-81.	The	microscope	consisted	of	a	100-watt	halogen	lamp,	used	for	transmission	microscopy.	In	addition,	the	microscope	consisted	of	a	100-watt	mercury	lamp	used	for	epiflourescent	microscopy.	The	components	of	the	microscope	consisted	of	a	reducer	lens,	two-piece	collimating	adapter,	a	liquid	crystal	tunable	filter,	and	a	CCD.	2-NBDG	excites	at	465nm,	and	emits	at	540nm	(4).	2-NBDG	was	excited	with	a	FITC	filter,	and	imaged	with	an	Olympus	camera.	300	microliters	of	2-NBDG	dissolved	in	glucose	free	media	(10:1	ratio)	was	flowed	through	the	channel	at	.5	microliters/min	for	20	minutes.	After	20	minutes,	the	cells	were	washed	with	glucose	free	media	to	remove	any	excess	2-NBDG	before	imaging.	The	cells	were	imaged	with	an	integration	time	of	1s.			
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Figure	2.	Imaging	platform.		
	
Results	and	Discussion	
	
Smaller	port	size	and	PDMS	coating	decreases	device	leakage	
	 Several	adjustments	to	the	device	were	made	to	inhibit	leakage	of	fluid	from	the	device.	High	amounts	of	leakage	occurred	at	the	inlet	and	outlet	ports	of	the	device,	and	at	the	bottom	of	the	device.	This	leakage	was	due	to	high	amounts	of	pressure	occurring	within	the	channel,	especially	at	the	ports.	This	leakage	became	problematic,	and	resulted	in	eventual	coverslip	detachment	from	the	PDMS.	Several	structural	changes	to	the	device	decreased	device	leakage,	helping	to	promote	device	attachment,	and	preventing	coverslip	detachment	from	PDMS.	First,	the	inlet	and	outlet	port	of	the	channel	was	decreased	in	size.	The	port	size	was	decreased	from	1/8	inch	in	diameter	to	.75mm	in	diameter.	This	decreased	the	amount	of	pressure	due	to	accumulation	of	fluid	at	the	ports.	Second,	PDMS	was	cured	around	
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the	glass	coverslip	to	seal	the	bond	between	the	coverslip	and	PDMS.	This	strengthened	the	adhesion	of	the	coverslip	and	PDMS,	and	inhibited	coverslip	detachment	from	the	PDMS.	Third,	a	coverslip	alcohol	wash	was	removed	from	the	protocol.	This	coverslip	wash	might	have	affected	the	attachment	between	the	glass	coverslip	and	PDMS.	This	process	was	replaced	by	cleaning	the	coverslip	with	air	prior	to	coverslip	attachment	to	PDMS.	Lastly,	the	tubing	at	the	entry	and	exit	ports	was	sealed	with	PDMS.	This	increased	the	bonding	between	the	tubing	and	PDMS,	and	decreased	leakage	at	the	ports.	These	structural	changes	led	to	an	increase	in	device	functionality.	The	devices	could	withstand	higher	flow	rates,	and	could	be	reused	without	a	loss	in	device	performance.			
Functional	flow	rates	increased	for	microfluidic	device	
	 Functional	flow	rates	for	the	device	were	determined	by	experimental	and	quantitative	methods.	This	was	completed	by	using	PBS,	in	conjunction	with	a	dye,	and	by	using	Poisseuille’s	law.	The	PBS	and	dye	mixture	was	used	to	visualize	leakage	through	the	device.	Structural	changes	in	the	device	increased	the	functional	flow	rates	for	the	device.	Initially,	the	device	had	small	amounts	of	success	at	low	flow	rates.	The	coverslip	would	detach	from	the	device,	or	the	device	would	experience	high	amounts	of	leakage.	The	functional	flow	rates	increased	from	10	microliters/min	to	flow	rates	of	50	microliters/min	and	higher.	These	experiments	provided	a	qualitative	representation	to	determine	a	range	of	functional	flow	rates	for	the	device.	These	flow	rates	were	then	verified	using	quantitative	calculations.	Poisseuille’s	Law	was	used	to	calculate	the	maximum	functional	flow	rate	for	the	
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channel	based	on	channel	parameters.	Assuming	a	maximum	pressure	of	300kPa,	the	maximum	flow	rate	was	determined	to	be	1.23e13	microliters/min.	These	calculations	were	used	to	ensure	that	the	qualitatively	determined	flow	rates	were	less	than	the	calculated	maximum	flow	rate.	After	determining	functional	flow	rates	for	the	device,	flow	rates	that	model	in	vivo	flow	rates	were	determined.	A	range	of	in	vivo	flow	velocities	was	given	from	a	study	conducted	by	Frees	et	al	(2).	This	range	was	used	to	calculate	viable	flow	rates	based	on	the	channel	parameters.	This	range	was	determined	to	be	from	.75-3.75	microliters/min.	These	flow	rates	were	determined	to	be	used	in	2-NBDG	experimentation.			
Improvements	in	cell	culturing	allows	for	cell	attachment	within	channel		 Several	adjustments	in	cell	culturing	techniques	initiated	cell	attachment	within	the	channel.	The	cells	were	first	cultured	on	a	glass	coverslip	prior	to	attachment	with	the	PDMS	mold.	This	method	of	cell	culturing	had	no	success.	It	inhibited	bonding	between	the	coverslip	and	PDMS,	and	prevented	formation	of	the	channel.	Higher	success	was	observed	when	injecting	cells	inside	the	channel	after	the	device	had	already	been	fabricated.	This	method	did	not	interfere	with	the	bonding	of	the	PDMS	and	coverslip.	To	inject	cells	inside	the	channel,	a	syringe	pump	was	used	at	a	uniform	flow	rate.	This	method	was	problematic	because	no	cells	were	observed	inside	the	channel	after	pumping.	The	flow	rates	for	the	syringe	pump	were	slow.	This	might	have	allowed	for	cell	accumulation	inside	the	tubing	or	in	the	bottom	of	the	syringe.	The	second	method	for	cell	injection	involved	injecting	cells	manually	with	a	syringe	and	a	small	piece	of	tubing	inserted	at	the	entry	port.	
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Cells	were	visualized	inside	the	channel	after	injection	with	this	method.	The	cell	count	was	increased	to	6,000,000	cells/ml	to	improve	cell	visualization	inside	the	channel,	and	gelatin	improved	cell	attachment	inside	the	channel.	After	injection,	cells	showed	a	tendency	to	exit	the	channel	due	to	capillary	action.	Capillary	action	is	the	result	of	high	pressure	inside	the	channel.	To	keep	cells	from	exiting	the	channel,	the	tubing	was	capped	or	adjusted.	The	cells	could	also	be	removed	if	the	media	was	perfused	to	quickly.	A	slow	perfusion	rate	was	chosen	to	inhibit	this	effect.	Incubation	time	also	affected	the	results	of	this	study.	In	one	experiment,	the	cells	were	cultured	inside	the	channel	for	72	hours.	Cells	accumulated	within	the	channel,	and	obstructed	2-NBDG	flow	during	imaging.	It	was	determined	that	the	incubation	time	should	be	decreased	to	ensure	proper	flow	mechanics	within	the	channel.		
	
Figure	3.	a)	Brightfield	image	of	the	microfluidic	channel	prior	to	cell	injection	(4X).	b)	Brightfield	image	of	the	microfluidic	channel	injected	with	4T1	cells	(10X).		
	
2-NBDG	fluorescence	observed	at	.5	microliters/min	
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	 Fluorescence	was	observed	as	2-NBDG	was	flowed	through	the	microfluidic	device.	This	flow	rate	was	chosen	so	that	the	cells	would	not	be	removed	upon	fluid	flow,	and	it	modeled	in	vivo	blood	flow	rates.	An	increase	in	fluorescence	was	observed	as	2-NBDG	entered	the	channel.	The	highest	intensity	of	fluorescence	is	observed	after	20	minutes	of	2-NBDG	flow.	The	intensity	of	2-NBDG	fluorescence	decreased	as	the	remaining	2-NBDG	was	removed	with	glucose	free	media.	The	remaining	cells	fluoresced	visibly.	The	cells	showed	higher	fluorescence	than	its	surrounding	environment.	The	concentration	of	2-NBDG	could	have	been	increased	to	increase	fluorescence	intensity	observed	for	the	cells.	Only	one	flow	rate	was	tested	for	2-NBDG	imaging.	To	determine	the	effect	of	flow	rates	on	glucose	uptake,	multiple	flow	rates	should	be	testing	in	the	future.	These	flow	rates	should	be	chosen	based	on	the	in	vivo	flow	rates	previously	determined.				 		 	
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Figure	4.	a)	Brightfield	image	post	4T1	cell	injection	(10X).	b)	Image	of	cells	24	hours	post	incubation	and	prior	to	2-NBDG	flow	(4X).	c)	Image	of	cells	after	20	mins	of	2-NBDG	flow	(10X).	d)	Image	of	cells	after	washing	with	glucose	free	media	(10X).		
	 	
Conclusion	Measurement	of	glucose	uptake	is	important	in	determining	tumor	response	to	radiation.	We	have	shown	that	the	microfluidic	device	manufactured	in	this	study	is	a	suitable	device	in	allowing	2-NBDG	flow.	We	have	determined	in	vivo	flow	rates	for	future	experimentation.	In	addition,	we	have	described	valuable	experimental	techniques	for	the	continuation	of	this	study	in	applying	varying	flow	rates	and	measuring	glucose	uptake.	Future	studies	must	be	conducted	with	increasing	flow	rates	to	determine	the	effect	on	glucose	uptake.	Previous	studies	have	shown	valuable	indications	that	2-NBDG	can	be	successful	as	a	biomarker	for	measuring	glucose	uptake	in	the	future.	The	continuation	of	this	study	will	be	important	in	determining	initial	metabolic	demand,	and	thus,	providing	clinical	significance	in	staging	cancers	and	determining	the	response	of	radiation	therapy.			
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